Drugs & Targets FDA grants Fast Track designation to PDS0101 + Keytruda in recurrent or metastatic HPV16-positive HNC June 03, 2022Vol.48 No.22
Drugs & Targets OncoHealth, Blue Note Therapeutics partner to provide a digital therapeutic for cancer-related anxiety and depression June 03, 2022Vol.48 No.22
Drugs & Targets C2i Genomics, Karkinos Healthcare partner to bring AI-powered cancer R&D to India June 03, 2022Vol.48 No.22
Drugs & Targets FDA grants marketing authorization to Parsortix System for liquid biopsy in MBC May 27, 2022Vol.48 No.21
Drugs & Targets FDA approves Tibsovo + Vidaza in IDH1-mutant newly diagnosed AML May 27, 2022Vol.48 No.21
Drugs & Targets Friends study: drugs that earn Breakthrough Therapy Designation at FDA provide maximum benefit in lung cancer May 27, 2022Vol.48 No.21
Drugs & Targets EMA adopts positive opinion for Keytruda in melanoma following complete resection May 27, 2022Vol.48 No.21
Drugs & Targets Case Western, Picture Health partner to develop AI tools for lung cancer May 27, 2022Vol.48 No.21
